Get Started

BBTX

NASD Bambusa Therapeutics, Inc.
Nov 2, 2026 · 8:23 AM ET LAST TRADE Market Closed

$14.42 ↓ -0.57 (-3.80%) Trading Down from the previous close of $14.99

YTD change
-3.80%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$13.60 $15.66
open $14.88 close $14.99
+$0.11 (+0.74%)
Today
$0.00 $0.00
$14.42
Past week
$0.00 $14.99
from $14.99 now $14.42
-$0.57 (-3.80%)
Past month
$0.00 $14.99
from $14.99 now $14.42
-$0.57 (-3.80%)
This year
$13.60 $15.66
from $14.99 now $14.42
-$0.57 (-3.80%)

Price & Performance

+0.00 (+0.00%) / 6M

No chart data available

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 7.9% away from all-time highs of $15.66
  • BBTX is down 4% since the beginning of the year
  • BBTX is down 4% over the past 12 months
  • BBTX is down 4% over the past 1 month

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $107.4M

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$90.6M
Debt$135.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $115.5M

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.